Showing results (421-430 of 565) with videos related to

Sort By:
Pageof 57
United European Gastroenterology Journal|April 15, 2026
Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY TrialsJean-Frédéric Colombel, Silvio Danese, Stefan Schreiber, et al.
Inflammatory Bowel Diseases|March 6, 2018
Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction TherapyParita Patel, Andres Yarur, Sushila Dalal, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 30, 2025
Clinical outcomes in Crohn's disease patients with short bowel syndrome on home parenteral nutrition are comparable to those with short bowel syndrome from other etiologiesAlexa N Sasson, Jessica Noelting, Katherine J P Schwenger, et al.
Inflammatory Bowel Diseases|July 17, 2015
Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's DiseasePatricia L Pringle, Kathleen O Stewart, Joanna M Peloquin, et al.
Human Genetics|July 27, 2014
Improving the power of genetic association tests with imperfect phenotype derived from electronic medical recordsJennifer A Sinnott, Wei Dai, Katherine P Liao, et al.
Inflammatory Bowel Diseases|May 19, 2012
Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel diseaseFrank Hoentjen, Margien L Seinen, Stephen B Hanauer, et al.
Gastrointestinal Endoscopy|January 9, 2018
Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel diseaseNoa Krugliak Cleveland, Dezheng Huo, Farah Sadiq, et al.
Nutrition and Healthy Aging|April 28, 2017
A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activitySumit Bhattacharyya, Theresa Shumard, Hui Xie, et al.
Gastroenterology & Hepatology|November 15, 2023
MMX Mesalamine for Induction and Maintenance Therapy in Mild-to-Moderate Ulcerative ColitisStephen B Hanauer, Gary R Lichtenstein, Michael A Kamm, et al.
Inflammatory Bowel Diseases|January 9, 2007
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximabBruce E Sands, Richard Kozarek, Jack Spainhour, et al.
Pageof 57